查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433372

全球更年期市场 2023-2030

Global Menopause Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 240 Pages | 商品交期: 2-3个工作天内

价格

预计在预测期内（2023-2030），全球更年期市场将以 5.37% 的CAGR成长。市场的成长归因于医疗保健支出的增加。随着人们对健康和福祉的日益关注，更年期管理和缓解产品及服务的支出也随之增加。例如，2023年7月，Slimming Sprinkles推出了一个专为围绝经期、更年期或绝经后以及经历重大荷尔蒙和生理变化的女性设计的综合性新在线平台，为更年期女性提供准确且经过充分研究的信息。

细分市场前景

全球更年期市场按组件、部署模式、组织规模和产业垂直细分。根据组件，市场分为解决方案和服务。根据部署模式，市场分为本地部署和云端部署。根据组织规模，市场分为大型企业和中小企业。此外，根据垂直产业，市场细分为消费品和零售、製造、能源和公用事业、运输和物流、航空航太和国防、IT和电信、医疗保健和生命科学等。 OTC 药品子类别预计将占据该产品领域的很大一部分市场份额。这可以归因于製药公司生产用于治疗更年期症状的非处方药的潜力的转变。

膳食补充剂细分市场预计将在全球更年期市场中占据相当大的份额

在治疗领域中，膳食补充剂细分市场预计将在全球更年期市场中占据相当大的份额。细分市场的成长归因于消费者的偏好。天然或植物疗法越来越受欢迎，尤其是在更年期女性中。具有多系统优势并由天然来源生产的补充剂经常受到这一人群的热烈欢迎。例如，2022 年 10 月，PharmaLinea 推出了先进的「全身」更年期补充品。它不仅可以缓解疼痛，还有益于心臟代谢、大脑和骨骼健康。研究发现，与安慰剂相比，Meno Ease 可将疼痛强度降低 27%。这表明它是一种有效的更年期补充剂，对受雌激素水平降低影响的各个身体系统具有潜在的益处。

区域展望

全球更年期市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本、韩国、亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，由于该类别同时包含发展中经济体和已开发经济体，预计亚太地区将在全球市场中占据显着份额。医疗保健成本的上升预计将推动该行业的发展。日本等人口老化国家的发展预计将推动该地区的市场。

北美地区预计全球更年期市场复合CAGR显着成长

在所有地区中，北美地区预计在预测期内将以相当大的CAGR成长。区域成长归因于健康和保健意识。随着人们健康意识的增强，并寻求随着年龄的增长保持令人满意的生活水平的策略，人们对更年期相关的健康产品和服务越来越感兴趣。这一趋势正在推动更年期市场向前发展。根据全球公共卫生，2020年11月，工业化国家的平均停经年龄为51岁，预期寿命为80.8岁。这意味着女性大约三分之一的寿命是在更年期后度过的。在美国，每天约有 6,000 名女性进入更年期，每年约有 200 万人进入更年期。

市场参与者展望

服务更年期市场的主要公司包括拜耳公司、雷迪博士实验室有限公司、默克公司、诺和诺德公司、宝洁公司等。市场参与者透过各种策略（包括併购、合作、合作、融资和新产品发布），为市场成长做出了巨大贡献，以保持市场竞争力。例如，2022 年 11 月，Northwell Holdings 与 Aegis Ventures 合作成立了 Upliv，这是一家女性虚拟护理新创公司，希望为临床更年期支持设定标准。 Upliv 与公司合作，为患有围绝经期和更年期症状的员工提供虚拟远距医疗服务以及全人护理。

报告涵盖：

  • 2022年市场价​​值资料分析及2030年预测。
  • 每个细分市场的年化市场收入（百万美元）。
  • 主要地理区域的国家分析。
  • 在全球更年期市场中营运的主要公司。根据现有资料，报告中还提供了与新产品发布相关的资讯以及相关新闻。
  • 透过确定未来强劲成长的关键细分市场来分析业务策略。
  • 市场进入和市场扩张策略分析。透过识别市场中「谁的立场」来制定竞争策略。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Abbott Healthcare Pvt.ltd.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • AbbVie
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • At F. Hoffmann-La Roche Ltd
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 2 章：市场细分

  • 按治疗分類的全球更年期市场
    • 膳食补充剂
    • 非处方药产品
      • *荷尔蒙
      • *非荷尔蒙
  • 按给药途径分類的全球更年期市场
    • 专题
    • 可注射
    • 口服
  • 按配销通路分類的全球更年期市场
    • 机构销售
    • 零售销售
    • 网上销售

第 3 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 4 章：公司简介

  • Bayer AG
  • Bionova
  • Biosante
  • Church & Dwight Co., Inc.
  • Dr.Reddy's Laboratories Ltd.
  • Duchesnay
  • Eli Lilly and Company India Pvt. Ltd.
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • Padagis US LLC
  • Pfizer
  • Procter & Gamble
  • Pure Encapsulations
  • Teva Pharmaceutical Industries Ltd.
  • Theramex HQ UK Ltd.
Product Code: OMR2027953

Global Menopause Market Size, Share & Trends Analysis Report by Treatment (Dietary Supplements, OTC Pharma Products, Hormonal, and Non-hormonal), by Route of Administration (Topical, Injectable, and Oral), and by Distribution Channel (Institutional Sales, Retail Sales, and Online Sales), Forecast Period (2023-2030)

The global menopause market is anticipated to grow at a CAGR of 5.37 % during the forecast period (2023-2030). The market's growth is attributed to increasing healthcare expenditure. With an increasing focus on health and wellbeing, there is an increase in spending on menopausal management and relief products and services. For instance, in July 2023, Slimming Sprinkles launched a comprehensive new online platform designed exclusively for women who are perimenopausal, menopausal, or postmenopausal and experiencing major horm and physiological changes to provide accurate and well-researched information to menopausal women.

Segmental Outlook

The global menopause market is segmented on the component, deployment mode, organization size and industry vertical. Based on the component, the market is sub-segmented into solution, and services. Based on the deployment mode, the market is sub-segmented into on-premise, and cloud. Based on the organization size, the market is sub-segmented into large enterprises, and small & medium sized enterprises. Furthermore, on the basis of industry vertical, the market is sub-segmented into consumer goods and retail, manufacturing, energy and utilities, transport and logistics, aerospace and defense, it and telecom, healthcare and life sciences, and others. The OTC Pharma Products subcategory is expected to capture a significant portion of the market share within the product segment. This can be attributed to pharmaceutical companies' shifting potential of manufacturing OTC medications for the treatment of menopausal symptoms.

The Dietary Supplements Sub-Segment is Anticipated to Hold a Considerable Share of the global Menopause Market

Among the treatment, the dietary supplements sub-segment is expected to hold a considerable share of the global menopause market. The segmental growth is attributed to the consumer preferences. Natural or plant-based therapies have grown more popular, particularly among menopausal women. Supplements that provide multi-system advantages and are produced from natural sources are frequently warmly received by this demographic. For instance, in October 2022, PharmaLinea launched advanced 'whole body' menopause supplement. It offers pain relief in addition benefiting cardio-metabolic, brain, and bone health. Meno Ease' has been found to reduce pain intensity by 27% compared to a placebo. This indicates that it is an effective menopause supplement with potential benefits for various body systems affected by reduced oestrogen levels.

Regional Outlook

The global menopause market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to category contains both developing and developed economies. Rising healthcare costs are projected to fuel the industry. The development of countries with increasing aging populations, such as Japan, is expected to drive the market in the region.

The North America Region is Expected to Grow at a Significant CAGR in the global Menopause Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the health and wellness awareness. As individuals have grown health-conscious and seek strategies to preserve a satisfactory standard of life as they age, there is a growing interest in menopause-related health products and services. This trend is propelling the menopausal market forward. According to the Global Public Health, in November 2020, the average age of menopause in industrialized countries is 51 years, and life expectancy is 80.8 years. This means that women spend around one-third of their lifespan in postmenopause. In the US, around 6,000 women reach menopause daily, and approximately 2 million reach menopause every year.

Market Players Outlook

The major companies serving the menopause market includes Bayer AG, Dr.Reddy's Laboratories Ltd, Merck & Co., Inc., Novo Nordisk A/S, Procter & Gambleand others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in November 2022, Northwell Holdings partnered with Aegis Ventures the formation of Upliv, a women's virtual care start-up that desires to set the bar for clinical menopause support. Upliv collaborates with companies to provide virtual telemedicine services in addition to whole-person care to employees suffering from perimenopause and menopausal symptoms.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global menopause market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott Healthcare Pvt.ltd.
    • 1.1.1. Overview
    • 1.1.2. Financial Analysis
    • 1.1.3. SWOT Analysis
    • 1.1.4. Recent Developments
  • 3.3. AbbVie
    • 1.1.5. Overview
    • 1.1.6. Financial Analysis
    • 1.1.7. SWOT Analysis
    • 1.1.8. Recent Developments
  • 3.4. At F. Hoffmann-La Roche Ltd
    • 1.1.9. Overview
    • 1.1.10. Financial Analysis
    • 1.1.11. SWOT Analysis
    • 1.1.12. Recent Developments
  • 1.2. Key Strategy Analysis

2. Market Segmentation

  • 2.1. Global Menopause Market by Treatment
    • 2.1.1. Dietary Supplements
    • 2.1.2. OTC Pharma Products
      • 2.1.2.1. *Hormonal
      • 2.1.2.2. *Non-hormonal
  • 2.2. Global Menopause Market by Route of Administration
    • 2.2.1. Topical
    • 2.2.2. Injectable
    • 2.2.3. Oral
  • 2.3. Global Menopause Market by Distribution Channel
    • 2.3.1. Institutional Sales
    • 2.3.2. Retail Sales
    • 2.3.3. Online Sales

3. Regional Analysis

  • 3.1. North America
    • 3.1.1. United States
    • 3.1.2. Canada
  • 3.2. Europe
    • 3.2.1. UK
    • 3.2.2. Germany
    • 3.2.3. Italy
    • 3.2.4. Spain
    • 3.2.5. France
    • 3.2.6. Rest of Europe
  • 3.3. Asia-Pacific
    • 3.3.1. China
    • 3.3.2. India
    • 3.3.3. Japan
    • 3.3.4. South Korea
    • 3.3.5. Rest of Asia-Pacific
  • 3.4. Rest of the World

4. Company Profiles

  • 4.1. Bayer AG
  • 4.2. Bionova
  • 4.3. Biosante
  • 4.4. Church & Dwight Co., Inc.
  • 4.5. Dr.Reddy's Laboratories Ltd.
  • 4.6. Duchesnay
  • 4.7. Eli Lilly and Company India Pvt. Ltd.
  • 4.8. Merck & Co., Inc.
  • 4.9. Novo Nordisk A/S
  • 4.10. Padagis US LLC
  • 4.11. Pfizer
  • 4.12. Procter & Gamble
  • 4.13. Pure Encapsulations
  • 4.14. Teva Pharmaceutical Industries Ltd.
  • 4.15. Theramex HQ UK Ltd.

LIST OF TABLES

  • 1. GLOBAL MENOPAUSE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 2. GLOBAL DIETARY SUPPLEMENTS MENOPAUSE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL OTC PHARMA PRODUCTS MENOPAUSE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL HORMONAL MENOPAUSE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL NON-HORMONAL MENOPAUSE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL MENOPAUSE MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION , 2022-2030 ($ MILLION)
  • 7. GLOBAL MENOPAUSE TOPICAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL MENOPAUSE INJECTABLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL MENOPAUSE ORAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL MENOPAUSE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 11. GLOBAL MENOPAUSE FOR INSTITUTIONAL SALES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL MENOPAUSE FOR RETAIL SALES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL MENOPAUSE FOR ONLINE SALES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL MENOPAUSE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION,2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 19. EUROPEAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. EUROPEAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 21. EUROPEAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)
  • 22. EUROPEAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC MENOPAUSE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC MENOPAUSE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 25. ASIA-PACIFIC MENOPAUSE MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)
  • 26. ASIA-PACIFIC MENOPAUSE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD MENOPAUSE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD MENOPAUSE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD MENOPAUSE MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION,2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD MENOPAUSE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL MENOPAUSE MARKET SHARE BY TREATMENT, 2022 VS 2030 (%)
  • 2. GLOBAL DIETARY SUPPLEMENTS MENOPAUSE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL OTC PHARMA PRODUCTS MENOPAUSE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL HORMONAL MENOPAUSE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL NON-HORMONAL MENOPAUSE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL MENOPAUSE MARKET SHARE BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
  • 7. GLOBAL MENOPAUSE TOPICAL MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL MENOPAUSE INJECTABLE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL MENOPAUSE ORAL MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL MENOPAUSE MARKET SHARE BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • 11. GLOBAL MENOPAUSE FOR INSTITUTIONAL SALES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL MENOPAUSE FOR RETAIL SALES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL MENOPAUSE FOR ONLINE SALES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL MENOPAUSE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. US MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. CANADA MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. UK MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. FRANCE MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. GERMANY MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. ITALY MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SPAIN MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF EUROPE MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. INDIA MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CHINA MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. JAPAN MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. SOUTH KOREA MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)